The identification of common genetic, molecular, and cellular pathogenic mechanisms in diabetes and rheumatoid arthritis may shed new light in the development of a metabolic disease during a chronic inflammatory process and may identify new specific targets to derive a precision medicine driven therapeutic strategy
Progetto vedi abstract in inglese